Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
Brompton Global Healthcare Income & Growth ETF (HIG : TSX)
Health Care Equity
Click for more information on Fundata’s FundGrade
FundGrade E
Click for more information on Fundata’s FundGrade.
Click for more information on Fundata’s ESG Grade
Fundata ESG Grade A
Click for more information on Fundata’s ESG Grade.
|
Close (07-06-2026) |
$7.49 |
|---|---|
| Change |
-$0.20
(-2.60%)
|
| Open | $7.42 |
|---|---|
| Day Range | $7.42 - $7.49 |
| Volume | 6,965 |
As at May 31, 2026
As at May 31, 2026
As at May 31, 2026
Loading......
Loading......
Legend
Compare Options
Fund Returns
Inception Return (September 24, 2015): 4.62%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -0.32% | -11.47% | -9.34% | -7.16% | 3.10% | -1.30% | 3.21% | 0.57% | 1.00% | 3.07% | 4.28% | 4.93% | 4.36% | 4.67% |
| Benchmark | 3.08% | -5.41% | -4.74% | -1.94% | 12.98% | 4.54% | 6.89% | 6.90% | 6.05% | 5.91% | 8.47% | 8.55% | 8.21% | 8.46% |
| Category Average | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Category Rank | 52 / 55 | 54 / 54 | 44 / 53 | 42 / 53 | 45 / 53 | 38 / 51 | 31 / 45 | 41 / 43 | 35 / 41 | 27 / 38 | 35 / 37 | 25 / 34 | 26 / 30 | 25 / 29 |
| Quartile Ranking | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 4 | 4 | 3 | 4 | 3 | 4 | 4 |
Monthly Return
| Return % | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 0.84% | -3.47% | 4.17% | 1.33% | 4.55% | 5.88% | -2.35% | 1.12% | 3.71% | -7.96% | -3.51% | -0.32% |
| Benchmark | 0.91% | -0.60% | 4.16% | 2.38% | 3.42% | 7.21% | -2.85% | 0.25% | 3.41% | -6.17% | -2.20% | 3.08% |
Best Monthly Return Since Inception
10.62% (April 2020)
Worst Monthly Return Since Inception
-11.20% (January 2022)
Calendar Return (%)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -6.29% | 11.24% | 4.97% | 21.97% | 6.28% | 24.13% | -14.33% | -1.52% | -0.13% | 13.47% |
| Benchmark | -8.68% | 14.01% | 11.82% | 17.06% | 13.59% | 15.28% | -1.72% | 1.42% | 9.95% | 9.64% |
| Category Average | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | 1 | 2 | 3 | 1 | 4 | 1 | 4 | 4 | 4 | 1 |
| Category Rank | 7/ 29 | 12/ 29 | 21/ 34 | 4/ 36 | 36/ 37 | 3/ 40 | 41/ 42 | 37/ 43 | 47/ 50 | 8/ 52 |
Best Calendar Return (Last 10 years)
24.13% (2021)
Worst Calendar Return (Last 10 years)
-14.33% (2022)
Asset Allocation
| Name | Percent |
|---|---|
| US Equity | 79.76 |
| International Equity | 19.32 |
| Cash and Equivalents | 0.92 |
Sector Allocation
| Name | Percent |
|---|---|
| Healthcare | 86.50 |
| Consumer Services | 8.58 |
| Real Estate | 4.00 |
| Cash and Cash Equivalent | 0.92 |
Geographic Allocation
| Name | Percent |
|---|---|
| North America | 80.68 |
| Europe | 19.32 |
Top Holdings
| Name | Percent |
|---|---|
| Novartis AG - ADR | 5.55 |
| Johnson & Johnson | 5.36 |
| Eli Lilly and Co | 5.20 |
| Gilead Sciences Inc | 5.15 |
| Bristol-Myers Squibb Co | 4.67 |
| Cardinal Health Inc | 4.65 |
| UnitedHealth Group Inc | 4.62 |
| Agilent Technologies Inc | 4.61 |
| Vertex Pharmaceuticals Inc | 4.27 |
| Merck & Co Inc | 4.14 |
Equity Style
Fixed Income Style
Risk vs Return (3 Yr)
Brompton Global Healthcare Income & Growth ETF
Median
Other - Health Care Equity
3 Yr Annualized
| Standard Deviation | 12.60% | 15.05% | 14.11% |
|---|---|---|---|
| Beta | 0.97% | 1.13% | 1.04% |
| Alpha | -0.03% | -0.05% | -0.04% |
| Rsquared | 0.75% | 0.79% | 0.73% |
| Sharpe | 0.03% | -0.05% | 0.26% |
| Sortino | 0.11% | -0.08% | 0.26% |
| Treynor | 0.00% | -0.01% | 0.04% |
| Tax Efficiency | 5.11% | - | - |
| Volatility |
|
|
|
Risk Rating
Annualized Key Ratio Period Comparison
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 14.10% | 12.60% | 15.05% | 14.11% |
| Beta | 1.04% | 0.97% | 1.13% | 1.04% |
| Alpha | -0.10% | -0.03% | -0.05% | -0.04% |
| Rsquared | 0.87% | 0.75% | 0.79% | 0.73% |
| Sharpe | 0.12% | 0.03% | -0.05% | 0.26% |
| Sortino | 0.10% | 0.11% | -0.08% | 0.26% |
| Treynor | 0.02% | 0.00% | -0.01% | 0.04% |
| Tax Efficiency | - | 5.11% | - | - |
Fundata ESG Metrics
Fundata ESG Score
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Fundata E Score
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Fundata S Score
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Fundata G Score
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
Fund Details
| Start Date | September 24, 2015 |
|---|---|
| Instrument Type | Exchange Traded Fund |
| Share Class | Do-It-Yourself |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Monthly |
| Assets ($mil) | - |
| 52 Week High | $8.30 |
| 52 Week Low | $6.81 |
| Annual Dividend | $0.66 |
| Annual Yield | - |
| Index | - |
| Shares Outstanding | - |
| Registered Plan Eligible | Yes |
ETF Characteristics
| Exposure | 1x performance |
|---|---|
| Asset Class High | - |
| Asset Class Medium | - |
| Asset Class Low | - |
| Leveraged | - |
| Inverse | - |
| Advisor Series | - |
| Covered Call Strategy | Yes |
Investment Objectives
The investment objectives of the Brompton ETF are to provide Unitholders of the Brompton ETF with: (a) stable monthly cash distributions; (b) the opportunity for capital appreciation; and (c) lower overall volatility of portfolio returns than would otherwise be experienced by owning securities of Healthcare Companies (as defined herein) directly. The Brompton ETF seeks to hedge substantially all of its direct exposure to foreign currencies back to the Canadian dollar.
Investment Strategy
The investment strategy of the Brompton ETF is to provide investors with exposure to an actively managed portfolio of equity securities of large capitalization global Healthcare Companies. To be considered for inclusion in the Brompton ETF's portfolio, at the time of investment, each Healthcare Company comprising the Brompton ETF's portfolio must have a market capitalization of at least $5 billion. The Manager employs a top-down, bottom-up approach.
Portfolio Management
| Portfolio Manager |
Brompton Funds Limited
|
|---|---|
| Sub-Advisor |
- |
Management and Organization
| Fund Manager |
Brompton Funds Limited |
|---|---|
| Custodian |
CIBC Mellon Trust Company |
| Registrar |
TSX Trust Company |
| Distributor |
- |
Fees
| MER | 0.96% |
|---|---|
| Management Fee | 0.75% |
Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
